Advances in the treatment of metastatic prostate cancer: Trends in Cancer
Prostate Cancer - TREATMENT - Uroweb
Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer: Results From a Phase 2 Trial - Advances in Radiation Oncology
Novel Targets and Treatment Developments in Metastatic Hormone Sensitive Prostate Cancer
Advanced Prostate Cancer: AUA/SUO Guideline - American Urological Association
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol - The
Full article: Docetaxel radiosensitizes castration-resistant prostate cancer by downregulating CAV-1
Sequencing of Systemic Therapies in the Management of Advanced Prostate Cancer in India: a Delphi-Based Consensus | Oncology and Therapy
Indication and perspectives of radiation therapy in the setting of de-novo metastatic prostate cancer - ScienceDirect
Metastatic Castration-Sensitive Prostate Cancer: Optimizing Patient Selection and Treatment | American Society of Clinical Oncology Educational Book
Relugolix: A Review in Advanced Prostate Cancer | Targeted Oncology
Current Oncology | Free Full-Text | Addition of New Androgen Receptor Pathway Inhibitors to Docetaxel and Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review and Metanalysis
Sequencing of Systemic Therapies in the Management of Advanced Prostate Cancer in India: a Delphi-Based Consensus | Oncology and Therapy
Modern treatment of metastatic prostate cancer | Tidsskrift for Den norske legeforening
Intermittent versus continuous androgen deprivation therapy for advanced prostate cancer | Nature Reviews Urology
Novel Targets and Treatment Developments in Metastatic Hormone Sensitive Prostate Cancer
Docetaxel Versus Surveillance After Radical Radiotherapy for Intermediate- or High-risk Prostate Cancer—Results from the Prospective, Randomised, Open-label Phase III SPCG-13 Trial - ScienceDirect
Salvage therapy for prostate cancer after radical prostatectomy | Nature Reviews Urology
Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations | Prostate Cancer and Prostatic Diseases
Modern treatment of metastatic prostate cancer | Tidsskrift for Den norske legeforening
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol - The
Prostate Cancer Treatment & Management: Approach Considerations, Localized Prostate Cancer, Management of Advanced and Metastatic Disease
Prostate Cancer - TREATMENT - Uroweb
Advanced Prostate Cancer: AUA/SUO Guideline - American Urological Association
Prostate Cancer - TREATMENT - Uroweb
Cardiovascular Safety of Degarelix Versus Leuprolide for Advanced Prostate Cancer: The PRONOUNCE Trial Study Design - ScienceDirect
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 5 (2019)
